Stēto develops Remote Patient Monitoring solutions against diabetes. 800M people worldwide will be suffering from diabetes in 2045. Healthcare systems around the globe are looking for new care organisations to tackle the issue, going beyond the usual ‘appointment every X months’. Our mission at Stēto is to imagine new models that will allow every patient to receive the daily medical support they need, and build the digital tools to bring them to life. We are a team of passionate healthcare professionals and technical experts, working hand in hand to change the way diabetes is treated. Join us in the adventure !
| Website | https://www.steto.care/ |
| Employees | 14 (8 on RocketReach) |
| Founded | 2022 |
| Industry | Technology, Information and Internet |
| Keywords | Remote Patient Monitoring, Diabetes Management, Chronic Disease Management, Telehealth Solutions, Digital Health, Health Monitoring Devices, Medical Devices, Wearable Health Tech, Remote Health Monitoring, Diabetes Care, Patient Monitoring Systems, Healthcare Technology, Medical Technology, Connected Health, Health Tech, Diabetes Technology, Remote Monitoring, Health Monitoring, Telemedicine, Personalized Medicine |
| Competitors | HealthTap, Teladoc Health, MDLIVE, by Evernorth, Lemonaid Health, PlushCare, doxy.me - telemedicine for all, Zocdoc, Amwell, Talkspace, Virtuwell +33 more (view full list) |
Looking for a particular Stēto employee's phone or email?
Vincent Chabot is the Co-Founder of Stēto.
8 people are employed at Stēto.
Stēto is based in Paris, Île-de-France.